Feb. 28, 2024
by Andrii Buvailo, PhD
News
It is a remarkable day for Ginkgo Bioworks, a notable player in the field of synthetic biology, as the company …
Feb. 24, 2024
by Andrii Buvailo
Biopharma insight
(Updated: 24.02.2024) Molecular mechanics (MM) is a traditional computational approach when it comes to modeling in synthetic organic chemistry, medicinal …
Feb. 24, 2024
by Andrii Buvailo, PhD
Biopharma insight
Quantum computing represents a monumental shift in the computational landscape, offering the potential to solve complex problems that are currently …
Feb. 13, 2024
by Dana Sokolova
Biopharma insight
The biotech and pharmaceutical industries are entering 2024 amid a wave of innovation and technological advancement. The biopharma field is …
Jan. 28, 2024
by Andrii Buvailo
Biopharma insight
Data is king in modern biopharmaceutical research, and ability to generate massive amounts of quality biomedical data represents a tremendous research …
Jan. 26, 2024
by Natalia Honchar
Biopharma insight
When we hear “AI in drug discovery”, there is a high chance our imagination would draw a small molecule discovery …
Jan. 26, 2024
by Andrii Buvailo, PhD
Biopharma insight
The year 2024 has ushered in a new wave of excitement in the biotech industry, with several promising companies making …
Jan. 25, 2024
by Dana Sokolova, Andrii Buvailo
Biopharma insight
Nearly two decades ago, a groundbreaking discovery in the field of biomedical research emerged, known as organ-on-a-chip technology, which quickly …
Jan. 25, 2024
by Andrii Buvailo
Biopharma insight
In the early 2000s, the concept of organ-on-a-chip technology, also known as microphysiological systems, emerged as a way to replicate …
Jan. 24, 2024
by Andrii Buvailo
Biopharma insight
According to a 2023 Deloitte report, "Sizing the Brain," by Álvaro Nuño Pérez, Jose M Suárez, and Michel LE BARS, providing an in-depth analysis of …
Jan. 23, 2024
by Andrii Buvailo
Interview
The development of oncology drugs faces significant challenges, including a high failure rate (97%) in clinical trials, due to complex …
Jan. 12, 2024
by Dana Sokolova
Biopharma insight
In 2023, the venture capital (VC) landscape witnessed significant activity, providing crucial support to the biotech sector amidst a volatile …